ADIL - CIK 0001513525
The table below shows ADIAL PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | $4.61M | $5.91M | $2.37M | $5.20M | $3.29M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.80M |
| $5.01M |
| $6.08M |
| $2.63M |
| $5.62M |
| $3.82M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $5.23M | $5.66M | $6.80M | $3.45M | $6.71M | $4.95M |
| Accounts payable | $573.57K | $556.28K | $671.12K | $532.43K | $318.12K | $316.73K |
| Total current liabilities | $1.51M | $1.15M | $1.21M | $1.32M | $829.05K | $671.88K |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.51M | $1.15M | $1.21M | $1.32M | $829.05K | $671.88K |
| Retained earnings | -$91.99M | -$87.98M | -$86.18M | -$84.22M | -$79.92M | -$77.73M |
| Total equity | $3.72M | $4.51M | $5.59M | $2.13M | $5.88M | $4.28M |